Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Sunrun Inc a un objectif de cours consensus de $17.45, basé sur les évaluations des 24 analystes. Le plus élevé est de $38 attribué par Evercore ISI Group le août 7, 2024, et le plus bas est de $6 attribué par Truist Securities le avril 16, 2025. Les 3 dernières évaluations d'analystes ont été publiées par RBC Capital, Wells Fargo et UBS le août 18, 2025, août 14, 2025 et août 8, 2025. Avec un objectif de cours moyen de $15.33 entre RBC Capital, Wells Fargo et UBS, il y a une variation implicite de -8.35% downside pour Sunrun Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
RBC Capital
Wells Fargo
UBS
JP Morgan
Oppenheimer
1calculé à partir des notes des analystes
Notes d'analystes pour Sunrun
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/18/2025 | -4.36% | RBC Capital | $12 → $16 | Upgrade | Sector Perform → Outperform | |||
08/15/2025 | — | GLJ Research | — | Upgrade | Sell → Hold | |||
08/14/2025 | -16.32% | Wells Fargo | $8 → $14 | Maintains | Overweight | |||
08/08/2025 | -4.36% | UBS | $15 → $16 | Maintains | Buy | |||
08/07/2025 | 19.55% | JP Morgan | $16 → $20 | Maintains | Overweight | |||
08/07/2025 | 25.52% | Oppenheimer | $20 → $21 | Maintains | Outperform | |||
08/07/2025 | -40.23% | BMO Capital | $8 → $10 | Maintains | Underperform | |||
08/07/2025 | -22.3% | Susquehanna | $12 → $13 | Maintains | Positive | |||
07/21/2025 | -28.27% | Susquehanna | $10 → $12 | Maintains | Positive | |||
07/15/2025 | -4.36% | JP Morgan | $13 → $16 | Maintains | Overweight | |||
07/14/2025 | 25.52% | Mizuho | $13 → $21 | Maintains | Outperform | |||
07/09/2025 | -34.25% | Jefferies | $5 → $11 | Upgrade | Underperform → Hold | |||
07/08/2025 | — | Keybanc | — | Upgrade | Underweight → Sector Weight | |||
06/25/2025 | -52.18% | Wells Fargo | $10 → $8 | Maintains | Overweight | |||
06/18/2025 | -70.11% | RBC Capital | $12 → $5 | Downgrade | Outperform → Sector Perform | |||
06/17/2025 | -64.14% | Keybanc | → $6 | Downgrade | Sector Weight → Underweight | |||
06/17/2025 | -99.94% | GLJ Research | $0.01 → $0.01 | Downgrade | Hold → Sell | |||
06/11/2025 | -70.11% | Jefferies | $6 → $5 | Downgrade | Hold → Underperform | |||
06/03/2025 | -28.27% | RBC Capital | $12 → $12 | Maintains | Outperform | |||
06/02/2025 | -22.3% | Mizuho | $16 → $13 | Maintains | Outperform | |||
05/30/2025 | -28.27% | UBS | $17 → $12 | Maintains | Buy | |||
05/30/2025 | -53.5% | GLJ Research | $7.78 → $7.78 | Upgrade | Sell → Hold | |||
05/28/2025 | -64.14% | Jefferies | $7 → $6 | Maintains | Hold | |||
05/22/2025 | -76.09% | BMO Capital | $9 → $4 | Downgrade | Market Perform → Underperform | |||
05/19/2025 | -10.34% | Goldman Sachs | $12 → $15 | Maintains | Buy | |||
05/14/2025 | 1.61% | UBS | $15 → $17 | Maintains | Buy | |||
05/08/2025 | -28.27% | RBC Capital | $14 → $12 | Maintains | Outperform | |||
04/17/2025 | -58.16% | Citigroup | → $7 | Downgrade | Buy → Neutral | |||
04/16/2025 | -64.14% | Truist Securities | $9 → $6 | Reiterates | Hold → Hold | |||
04/14/2025 | -40.23% | Susquehanna | $13 → $10 | Maintains | Positive | |||
04/10/2025 | -58.16% | Jefferies | $8 → $7 | Maintains | Hold | |||
03/12/2025 | -52.18% | Jefferies | $14 → $8 | Downgrade | Buy → Hold | |||
03/04/2025 | -10.34% | UBS | $17 → $15 | Maintains | Buy | |||
03/03/2025 | -16.32% | RBC Capital | $17 → $14 | Maintains | Outperform | |||
03/03/2025 | -46.2% | Truist Securities | $12 → $9 | Reiterates | Hold → Hold | |||
03/03/2025 | -10.34% | Goldman Sachs | $17 → $15 | Maintains | Buy | |||
03/03/2025 | -46.2% | BMO Capital | $11 → $9 | Maintains | Market Perform | |||
01/28/2025 | -10.34% | Barclays | $18 → $15 | Maintains | Equal-Weight | |||
01/28/2025 | 1.61% | Jefferies | $19 → $17 | Maintains | Buy | |||
01/23/2025 | 7.59% | JP Morgan | $22 → $18 | Maintains | Overweight | |||
01/10/2025 | 1.61% | UBS | $14 → $17 | Upgrade | Neutral → Buy | |||
01/08/2025 | -28.27% | Wells Fargo | $15 → $12 | Maintains | Overweight | |||
12/19/2024 | 25.52% | TD Cowen | → $21 | Initiates | → Buy | |||
12/17/2024 | 1.61% | Goldman Sachs | $19 → $17 | Maintains | Buy | |||
11/26/2024 | -16.32% | UBS | $18 → $14 | Maintains | Neutral | |||
11/22/2024 | -34.25% | Piper Sandler | $23 → $11 | Downgrade | Overweight → Neutral | |||
11/15/2024 | 61.39% | Morgan Stanley | $35 → $27 | Maintains | Overweight | |||
11/12/2024 | -28.27% | Truist Securities | $18 → $12 | Reiterates | Hold → Hold | |||
11/11/2024 | -34.25% | BMO Capital | $20 → $11 | Maintains | Market Perform | |||
11/08/2024 | 79.32% | Roth MKM | $35 → $30 | Maintains | Buy | |||
11/08/2024 | -10.34% | Wells Fargo | $20 → $15 | Maintains | Overweight | |||
11/08/2024 | 19.55% | Oppenheimer | $22 → $20 | Maintains | Outperform | |||
11/07/2024 | -53.5% | GLJ Research | → $7.78 | Downgrade | Hold → Sell | |||
11/07/2024 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
10/28/2024 | — | GLJ Research | — | Upgrade | Sell → Hold | |||
10/16/2024 | 7.59% | Barclays | $19 → $18 | Maintains | Equal-Weight | |||
10/16/2024 | 37.48% | Susquehanna | $24 → $23 | Maintains | Positive | |||
10/10/2024 | 73.34% | Jefferies | $31 → $29 | Maintains | Buy | |||
09/25/2024 | 19.55% | Goldman Sachs | $20 → $20 | Reiterates | Buy → Buy | |||
09/24/2024 | 109.21% | Morgan Stanley | $35 → $35 | Maintains | Overweight | |||
08/21/2024 | 109.21% | Morgan Stanley | $31 → $35 | Maintains | Overweight | |||
08/08/2024 | -1.37% | Deutsche Bank | $12 → $16.5 | Maintains | Hold | |||
08/08/2024 | 19.55% | Goldman Sachs | $18 → $20 | Maintains | Buy | |||
08/07/2024 | 31.5% | JP Morgan | $19 → $22 | Maintains | Overweight | |||
08/07/2024 | 7.59% | UBS | $14 → $18 | Maintains | Neutral | |||
08/07/2024 | 19.55% | BMO Capital | $17 → $20 | Maintains | Market Perform | |||
08/07/2024 | 127.14% | Evercore ISI Group | $42 → $38 | Maintains | Outperform | |||
08/07/2024 | 7.59% | Truist Securities | $12 → $18 | Reiterates | Hold → Hold | |||
08/07/2024 | 37.48% | Piper Sandler | $20 → $23 | Maintains | Overweight | |||
08/07/2024 | 31.5% | Oppenheimer | $19 → $22 | Maintains | Outperform | |||
07/23/2024 | 13.57% | Barclays | $16 → $19 | Maintains | Equal-Weight | |||
07/22/2024 | 19.55% | Piper Sandler | $15 → $20 | Maintains | Overweight | |||
07/16/2024 | 13.57% | JP Morgan | $14 → $19 | Maintains | Overweight | |||
07/15/2024 | 43.45% | Susquehanna | $23 → $24 | Maintains | Positive | |||
06/14/2024 | 73.34% | Morgan Stanley | $24 → $29 | Maintains | Overweight | |||
05/09/2024 | — | GLJ Research | — | Reiterates | → Sell | |||
05/09/2024 | 55.41% | Jefferies | $32 → $26 | Maintains | Buy | |||
05/09/2024 | 37.48% | Susquehanna | $25 → $23 | Maintains | Positive | |||
04/19/2024 | 37.48% | Mizuho | $28 → $23 | Maintains | Buy | |||
04/05/2024 | 49.43% | Susquehanna | → $25 | Maintains | Positive | |||
03/15/2024 | -10.34% | RBC Capital | $17 → $15 | Maintains | Outperform | |||
02/26/2024 | -16.32% | Truist Securities | $15 → $14 | Reiterates | Hold → Hold | |||
02/22/2024 | 61.39% | Piper Sandler | $31 → $27 | Maintains | Overweight | |||
02/22/2024 | 13.57% | Oppenheimer | $19 → $19 | Maintains | Outperform | |||
02/22/2024 | 19.55% | BMO Capital | $18 → $20 | Maintains | Market Perform | |||
02/22/2024 | 25.52% | Goldman Sachs | $20 → $21 | Maintains | Buy | |||
01/23/2024 | -10.34% | Truist Securities | $10 → $15 | Maintains | Hold | |||
01/04/2024 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
01/03/2024 | 67.36% | Mizuho | $23 → $28 | Maintains | Buy | |||
12/19/2023 | 85.3% | Piper Sandler | $15 → $31 | Upgrade | Neutral → Overweight | |||
12/18/2023 | 19.55% | Goldman Sachs | $17 → $20 | Maintains | Buy | |||
12/15/2023 | 49.43% | Jefferies | → $25 | Initiates | → Buy | |||
12/08/2023 | 43.45% | Morgan Stanley | $26 → $24 | Maintains | Overweight | |||
11/21/2023 | 37.48% | Mizuho | → $23 | Initiates | → Buy | |||
11/03/2023 | 109.21% | Roth MKM | $55 → $35 | Maintains | Buy | |||
11/03/2023 | 1.61% | Goldman Sachs | $19 → $17 | Maintains | Buy | |||
11/02/2023 | -4.36% | JP Morgan | $21 → $16 | Maintains | Overweight | |||
11/02/2023 | 25.52% | Susquehanna | $26 → $21 | Maintains | Positive | |||
11/02/2023 | -28.27% | Northland Capital Markets | → $12 | Downgrade | Outperform → Market Perform | |||
11/02/2023 | -28.27% | BMO Capital | → $12 | Downgrade | Outperform → Market Perform |
FAQ
Quel est le cours indicatif de l'action Sunrun (RUN) ?
Le dernier objectif de prix pour Sunrun (NASDAQ:RUN) a été rapporté par RBC Capital le août 18, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $16.00 s'attendant à ce que RUN se fall dans les 12 prochains mois (un possible changement de -4.36% downside). 60 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Sunrun (RUN) ?
La dernière note d'analyste pour Sunrun (NASDAQ:RUN) a été fournie par RBC Capital, et Sunrun amélioré leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Sunrun (RUN) ?
La dernière amélioration pour Sunrun Inc a eu lieu le août 18, 2025 lorsque RBC Capital a augmenté leur objectif de prix à $16. RBC Capital avait précédemment a sector perform pour Sunrun Inc.
Quand a eu lieu la dernière dégradation pour Sunrun (RUN) ?
La dernière réduction pour Sunrun Inc a eu lieu le juin 18, 2025 lorsque RBC Capital a changé leur objectif de prix de $12 à $5 pour Sunrun Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Sunrun (RUN) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Sunrun, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Sunrun a été déposée le août 18, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 18, 2026.
La note d'analyste pour Sunrun (RUN) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Sunrun (RUN) était un amélioré avec un objectif de prix de $12.00 à $16.00. Le prix actuel de Sunrun (RUN) est de $16.73, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.